Neocepri (folic acid)
- Region
- 🇪🇺 EU
- Active substance
- folic acid
- Company
- Endocyte Europe, B.V.
- Status
- Application withdrawn
- Therapeutic area
- Ovarian Neoplasms; Radionuclide Imaging
- Application
- EMEA/H/C/002773
- ATC
- V04
- Official record
- www.ema.europa.eu
Indication
Indicated for the enhancement of 99mTc-etarfolatide single photon emission computed tomography (SPECT) image quality
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇺🇸 Quiofic Approved · Solubiomix
Follow Neocepri
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.